The COVID-19 pandemic has evolved to immune escape and threatened small children and
the elderly with a higher severity and fatality of non-pulmonary diseases. These life …

Methods The relevant literature was reviewed using two independent computer search
engines, PubMed and Ovid. The literature review was continuously updated until nearly …

Importance Minimal data are available regarding the postdischarge treatment of multisystem
inflammatory syndrome in children (MIS-C). Objectives To evaluate clinical characteristics …

Background Paediatric inflammatory multisystem syndrome (PIMS) is a rare condition
temporally associated with SARS-CoV-2 infection. Using national surveillance data, we …

Multisystem inflammatory syndrome (MIS-C) is a rare condition associated with COVID-19
affecting children, characterized by severe and aberrant systemic inflammation leading to …

Multisystem inflammatory syndrome in children (MIS-C) is a relatively new syndrome
associated with coronavirus disease 2019 (COVID-19) that is characterized by a severe …

Background: The large-scale utilization of immunoglobulins in patients with inborn errors of
immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as …

We report a severe COVID-19 complicated with MIS-C in a girl treated by the author in
China, and discuss the current research status and progress in the diagnosis and therapy of …

Objectives To describe the clinico-laboratory profile, intensive care needs and outcome of
multisystem inflammatory syndrome in children (MIS-C) during the first and second waves …

Introduction As the global pandemic continues, new complications of COVID-19 in pediatric
population have turned up, one of them being hemolytic uremic syndrome (HUS), a …